Identifying Genetic Targets in Gynecological Tumors

Summary

This observational study aims to identfy genetic targets involved in the pathogenesis of gynecological tumors, with a focus on high-grade serous ovarian carcinoma. Using a triple approach - in silico, ex vivo and in vitro - the study will investigate the role of gonadotropins and their related signaling pathways in the epithelial ovarian cancers. Gene and protein expression levels will be evaluated through transcriptomic analysis, immunohistochemistry and functional assays on tumor cell lines. The goal is to uncover potential diagnostic or therapeutic targets in gynecological malignancies.

Eligibility

Inclusion Criteria:

* Adult women ≥18 years old
* Histologically confirmed diagnosis of epithelial ovarian cancer (including high- grade serous, endometrioid, mucinous, clear cell, or mesonephric-like histotypes)
* Signed informed consent (for prospective cases) or ethically approved waiver (for retrospective samples)

Exclusion Criteria:

* Refusal to sign informed consent
* Diagnosis of low-grade or non-epithelial ovarian tumors
* Patients whose clinical or pathological data are unavailable or insufficient for study inclusion

Conditions2

Browse More Trials